Evanthia Roussos Torres recently was awarded R01 funding from the National Cancer Institute to investigate how targeting myeloid suppression enhances anti-tumor immunity in breast cancer – Caryn Lerman

Congratulations to Dr. Evanthia Roussos Torres, member of the USC Norris Tumor Immunology & Microenvironment Program, who recently was awarded R01 funding from the National Cancer Institute to investigate how targeting myeloid suppression enhances anti-tumor immunity in breast cancer. Her work will reveal how epigenetic modulation of myeloid suppression in breast cancers can improve response to checkpoint inhibition, and, along with collaborators she will incorporate mathematical modeling that will decipher the complex and collective mechanisms of altered suppression, as well as predict tumor response to novel therapies.

Source: Caryn Lerman / Linkedin